ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, K.-J.
Right arrow Articles by Tseng, A. C.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, K.-J.
Right arrow Articles by Tseng, A. C.-C.

Ann Thorac Surg 2005;80:1371-1374
© 2005 The Society of Thoracic Surgeons

Original article: Cardiovascular

Serum S-100 ß Protein During Coronary Artery Bypass Graft Surgery With or Without Cardiopulmonary Bypass

Kuan-Jen Wang, MD a , Hsiang-Hua Wu, BA a , Shih-Yuan Fang, MD b , Yu-Ren Yang, MD, PhD c , A. Chia-Chih Tseng, MD a , *

a Department of Anesthesiology, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Kaohsiung, Taiwan
b Department of Anesthesiology, Medical Center, National Cheng Kung University, Tainan, Taiwan
c Department of Surgery, Medical Center, National Cheng Kung University, Tainan, Taiwan

Accepted for publication April 5, 2005.

* Address reprint requests to Dr Tseng, Department of Anesthesiology, Chang Gung Memorial Hospital, Kaohsiung Medical Center, 123 Ta Pei Rd, Niao Sung Hsiang, Kaohsiung Hsien 83301, Taiwan (Email: alex1115{at}adm.cgmh.org.tw).

BACKGROUND: Brain damage is a serious complication of cardiac anesthesia. The purpose of this study was to detect brain damage at different surgical stages during coronary artery bypass graft with or without cardiopulmonary bypass.

METHODS: We conducted a prospective, longitudinal study to evaluate serum S-100 ß protein, an early marker of brain injury, in patients electively undergoing off-pump (n = 30) or traditional coronary artery bypass graft (n = 60). Blood was sampled immediately before anesthesia, before and after cardiopulmonary bypass, and on the day after surgery.

RESULTS: Serum S-100 ß protein was lowest immediately before induction of anesthesia and significantly increased before and after cardiopulmonary bypass, then declined by the first postoperative day in both groups. Peak values were highest in the traditional group directly after coronary artery bypass graft. On the day after surgery, S-100 ß protein levels were similar between groups, but were higher than baseline within each group. Significant increase in serum S-100 ß protein was also observed even before cardiopulmonary bypass in cardiopulmonary bypass patients, or before manipulation of the heart and aorta in off-pump patients. These reflect the possibility that brain damage may occur before major manipulation (cardiopulmonary bypass or manipulating heart and aorta). Moreover, S-100 ß levels did not return to normal on the day after the operation.

CONCLUSIONS: This prospective study has shown that serum S-100 ß protein was not only higher than baseline both after cardiopulmonary bypass and on the day after surgery in both groups of patients but it was also significantly increased before cardiopulmonary bypass or manipulation of the heart or aorta. These findings may have implications for anesthesiologic care during the total course of cardiac surgery.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The Society of Thoracic Surgeons.